Incidence rates and characteristics of pediatric onset psychogenic nonepileptic seizures

Anne S Hansen1,2, Charlotte U Rask3,4, Maria Rodrigo-Domingo5

  • 1Unit for Psychiatric Research, Psychiatry, Aalborg University Hospital, Aalborg, Denmark. ansoha@rn.dk.

Pediatric Research
|May 12, 2020
PubMed

Insights

The incidence of pediatric psychogenic nonepileptic seizures (PNES) is rising in children and adolescents. This neurological and psychiatric disorder requires integrated healthcare approaches for effective management.

Area of Science:

  • Neurology
  • Child Psychiatry
  • Epidemiology

Background:

  • Pediatric onset psychogenic nonepileptic seizures (PNES) are disabling and often misdiagnosed as epilepsy.
  • Limited data exists on the incidence and characteristics of PNES in pediatric populations.
  • This study addresses the scarcity of information on pediatric PNES, including those with comorbid epilepsy.

Purpose of the Study:

  • To investigate the incidence rate (IR) of pediatric onset PNES.
  • To describe the clinical characteristics of pediatric PNES.
  • To explore differences in PNES characteristics when comorbid epilepsy is present.

Main Methods:

  • Population-based study using Danish healthcare registries (1996-2014).
  • Included children and adolescents aged 5-17 years with incident PNES diagnosis.
  • Diagnostic validity assessed via medical record review for 386 participants.

Main Results:

  • PNES incidence increased significantly from 1996 to 2014, peaking at 7.4 per 100,000 person-years.
  • Associated factors included history of neurologic/psychiatric issues and negative life events.
  • Comorbid epilepsy (14.2%) linked to intellectual disabilities, school support, and diagnostic delays.

Conclusions:

  • PNES diagnosis in children and adolescents is increasing.
  • The complex profile of neurologic and psychiatric issues necessitates collaborative pediatric and mental healthcare.
  • Findings inform future healthcare planning for pediatric PNES.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
130
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
169
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K